This blog is devoted to future of medicine, sceince, biogerontology and ageing, big data in biomedicine, robots.
Monday, November 30, 2015
The Future of Biotech Enterprise: Exponential Opportunities and Existential Risks
The future of biotechnology has many opportunities to create abundance, but also many risks for destruction. Dmitry Kaminskiy will be speaking with Professors Chris Lowe and Derek Smith about exponential opportunities and existential risks. This is certain to be a valuable and enlightening discussion!
Bioscience technologies have the power to build or destroy a world of health and abundance. Leveraging entrepreneurial opportunities whilst avoiding catastrophic risk is a balancing act with potentially fatal consequences.
Guest Speakers include:
Professor Chris Lowe OBE, FREng, FInstP, FRSC
- Emeritus Professor, Chemical Engineering and Biotechnology, University of Cambridge
- Awarded ‘most entrepreneurial scientist in the UK’, with research recognised by over 20 major national and international awards
Professor Derek Smith
- Professor of Infectious Disease Informatics, University of Cambridge
- Director of WHO Collaborating Centre for Modelling, Evolution and Control of Emerging Infectious Diseases
Dmitry Kaminskiy
- Founder and investor of Deep Knowledge Ventures, Deep Knowledge Life Sciences, OncoFinder, Insilico Medicine, Exponential Technologies Institute, and iBank.
- Developer of artificial intelligence systems VITAL, and SPOCK. Director of the Biogerontology Research Foundation
Refreshments will be provided after the talk.
Sponsored by: Deep Knowledge Ventures - Life Sciences, and BGRF
In collaboration with: Cambridge University Entrepreneurs, Centre for the Study of Existential Risk, Centre for the Advancement of Sustainable Medical Innovation, and Cambridge University Department of Chemical Engineering and Biotechnology
The event will take place on december 2 in The Queen's Lecture Theatre, Emmanuel College, Cambridge.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment